Navigation Links
Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Date:9/17/2007

NEW YORK, Sept. 17 /PRNewswire/ -- ExL Pharma is pleased to announce three Clinical Data Focused conferences which cover many of the leading issues that are impacting the pharmaceutical industry today. These events offer educational and networking opportunities for Clinical, R&D, Regulatory and Medical Affairs executives from large to small pharmaceutical, biotech, device and medical technology companies.

Listed below are details on some of the featured events and highlights from those conferences:

October 15-16, San Francisco, CA

2nd Data Monitoring Committees/DSMBs Conference -- Evaluating Trial Safety

and Efficacy through Independent Examination of Interim Clinical Data

Following a successful inaugural DMC conference in February of 2007, where over 100 industry experts gathered in Philly, ExL Pharma is proud to announce the 2nd DMC conference taking place October 15-16 in San Francisco where the industry will once again gather to evaluate trial safety and efficacy through independent examination of interim clinical data. Hear case study examples from GSK, AstraZeneca, Genentech, Amgen and join the industry's leading authorities on Drug Safety, Regulatory Affairs and Biostatistics to discuss experiences, strategies and best practices for working with DMCs and incorporating them into clinical trial designs to mitigate risk, optimize resource allocation, reassure study integrity and increase safety.

November 5-6, Arlington, VA

Pediatric Clinical Trials Conference -- Increasing Efficiency in Drug

Development by Redefining Global Regulation and Identifying Trial

Enhancements

Featuring roundtable discussions chaired by Dean Steven Spielberg from Dartmouth Medical School; topics lead by experts in each field include CNS/Psychiatry, Infectious Disease, Oncology, Gastroenterology, and Geographic Study Differences. Other event presentations include NICHD perspective on Best Pharmaceuticals for Children Act,
'/>"/>

SOURCE ExL Pharma
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Pharma majors gear to supply anti-anthrax drug
2. First Artificial Heart patient has Major setback
3. Allergies: A major health problem
4. Animal insulin product to be discontinued by drug major Eli Lilly
5. Vision Loss Due To Diabetic Retinopathy a Major Cause Of Concern
6. Depression Found To Be A Major Cause for Death in Elderly
7. Genetics Has A Major Role To Play In Body Shape.
8. “Yes, I need Cosmetic surgery” – view of majority wome
9. Pigs Population A Major Threat To Encephalitis Ravaged UP
10. Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India
11. Delhi Government To Interlink All Major Hospitals Through e-Governance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...tic children whose parents have high expectations ...kely to have symptoms than other children dealing ...dren also are more likely to use asthma controller...for taking medicine and if their parents clearly u... The study, which appears in the Oct. 2008 issue o...
(Date:10/3/2008)...ding is beneficial. But can it help kids lose weig...terature on obese adolescents, researchers at Duke...ight type of novel may make a difference. , The ...who were already in a comprehensive weight loss pr... Rescue (Beacon Street Press). It was carefully cr...
(Date:10/3/2008)... Inc. Magazine recently included,Connolly Consulti...ng,private companies in the country. The list is t...egment of the economy -- America,s,independent-min...es,represent the backbone of the U.S. economy., (...3/NY36880LOGO ), Connolly Consulting,s consisten...
(Date:10/3/2008)...idents to Eat Right, Move More and ...t. 3 /PRNewswire/ -- The last decade can be define...hich seem to go in and out,of fashion like shoulde...en,slim. Two out of three Americans -- including 2...weight or obese., A new campaign crossing the cou...
Breaking Medicine News(10 mins):Health News:Children's asthma affected by parental expectations 2Health News:Duke researchers show reading can help obese kids lose weight 2Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3
...icals has been known to be associated with health ...me immemorial. But it is known not until recently ...lowing occupational exposure to mineraloil. The ex...r remains unestablished. However, a number of gene...
...hildren who suffer from chronic sinusitis only whe...gests that life after surgery for these children b...first-line surgical therapy for chronic rhinosinus...c sinus surgery (FESS) is also being performed wit...
...ing the problem of stuttering early in life, like ... in curing the condition. The research report on t... BMJ. About 5% of children begin to stutter, usual...fe. The consensus is that early intervention in th...
...New York are under investigation for allegedly enr...ies and filing false information on protocols with...maintain government funding for a university resea...pediatric center accused the center’s director of ...
Other Medicine News:
(Date:10/6/2008)...se 3b Studies with Durezol Dosed Prior to Surgery,...peutics, Inc., a,privately held ophthalmic-focused...urezol(TM) (difluprednate ophthalmic emulsion) 0.0...as approved by the U.S. Food and,Drug Administrati...eroid,indicated for the treatment of inflammation ...
(Date:10/6/2008)...lif. and SEATTLE, Oct. 6 /- Complete,...human genome sequencing,company, and the Institute...artnership to conduct populationwide human genome ...enomics will use its proprietary,DNA sequencing te...vided by,ISB. Then, once proof-of-concept has been...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/6/2008)...Other Product - Company,s Bioabsorbable Stent - Al...G, Oct. 6 /- Data from multiple clini... OrbusNeich,s Genous Bio-engineered R,stent, will ...vascular,Therapeutics symposium, TCT 2008, in Wash...the Academic Medical Center in,Amsterdam will prov...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 1Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 8Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 1Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 2Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 3Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 1Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 2Food for thought 2735 2/ 1
... Jun 09, 2007 (MARKET WIRE via COMTEX News Network...sidiary of Endo,Pharmaceuticals Holdings Inc. (NAS... randomized, double-blind, placebo-controlled,clin...e) 2.5 mg,tablets as a six-day preventative treatm...raine (MM). The data demonstrated,that FROVA signi...
...., June 11, 2007--New research supported by the,...of Arthritis and,Musculoskeletal and Skin Diseas...ion gabapentin , which is used for certain,type...he pain and,other symptoms associated with the c..., fibromyalgia. , In the NIAMS-sponsored, random...
Other Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3
BiodivYsio stent with biocompatible coating (phosphorylcholine)
The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, s
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support.
Medicine Products: